Bogan Sleep Consultants, LLC | Columbia, SC

Research site

(Unclaimed)

Location

1333 Taylor St. 6B  Columbia, SC, Columbia, South Carolina, United States of America

Site insights

Top conditions

Top treatments

Daridorexant

Elinzanetant

MK-6552-004

TAK-861

SAR440340

JZP258-407

XYWAV

Dupilumab

High-Sodium Oxybate

MK-6552

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

9 of 10 total trials

A Study to Investigate the Effect of XYWAV on Sleepiness, Polysomnography, and Functional Outcomes in Participants With Idiopathic Hypersomnia or Narcolepsy

This study will assess the safety and efficacy of JZP258 (XYWAV) on sleepiness, polysomnography, and functional outcomes in patients with idiopathic...

Enrolling

Idiopathic Hypersomnia

Narcolepsy

Drug: JZP258 (XYWAV)

A Study to Learn About How Elinzanetant Works and How Safe it is in Women Having Sleep Disturbances Associated With Menopause (NIRVANA)

Researchers are looking for a better way to treat women who have sleep disturbances associated with menopause.Menopause is part of a natural aging pr...

Enrolling

Sleep Disturbances Associated With Menopause

Other: Placebo

Drug: Elinzanetant

A Switch Study From High-Sodium Oxybate to XYWAV to Evaluate Changes in Blood Pressure in Participants With Narcolepsy

The aim of this study is to quantify the change in blood pressure when participants with narcolepsy treated with high-sodium oxybate are transitioned...

Enrolling

Narcolepsy

Drug: JZP258

Dose-finding Study Assessing the Efficacy, Safety, and Pharmacokinetics of Daridorexant in Subjects Aged 10 to < 18 Years With Insomnia Disorder

This study assesses the efficacy, safety, and pharmacokinetics of multiple-dose oral administration of daridorexant in pediatric subjects aged 10 to...

Enrolling

Insomnia

Drug: Daridorexant 10 mg

Drug: Daridorexant 25 mg

Safety and Effectiveness of the Genio® bilAteral Stimulation for Treatment of Complete Concentric CollapsE and OSA. (ACCCESS)

The solution offered by the Genio System to treat OSA patients with CCC using bilateral HGNS has a favorable risk-benefit ratio, as demonstrated by e...

Enrolling

Sleep Apnea, Obstructive

Device: Genio System

Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe Asthma (ATLAS)

This is an interventional, randomized, parallel group, treatment, Phase 3b/4, double blind, 2-arm study to assess the effect of dupilumab compared to...

Enrolling

Asthma

Drug: Placebo

Drug: Dupilumab

Study of MK-6552 in Participants With Narcolepsy Type 1 (MK-6552-004)

The purpose of this study is to evaluate the safety, efficacy, pharmacokinetics (PK), and pharmacodynamics (PD) of MK-6552 in participants with Narco...

Enrolling

Narcolepsy

Drug: Placebo

Drug: MK-6552

Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD) (AERIFY-1)

Primary Objective:Evaluate the efficacy of itepekimab compared with placebo on the annualized rate of acute moderate-or-severe COPD exacerbations in...

Active, not recruiting

Chronic Obstructive Pulmonary Disease

Drug: Placebo

Drug: Itepekimab SAR440340

Treating Obstructive Sleep Apnea Using Targeted Hypoglossal Neurostimulation (OSPREY)

Multi-center, open-label, prospective, randomized clinical trial of the aura6000(R) System for the reduction of apnea and hypopneas in adult patients...

Active, not recruiting

Hypopnea, Sleep

Apnea, Obstructive Sleep

Device: Hypoglossal Nerve Stimulation